Further supporting this, large, multicenter genome-wide association studies have reported a high incidence of GBA mutations in patients with sporadic Parkinson’s disease and an increased risk of developing Parkinson’s disease in GBA carriers40. This evidence concerns the gene GBA1 and Parkinson disease.